These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23202946)

  • 1. Altered DNA binding and amplification of human breast cancer suppressor gene BRCA1 induced by a novel antitumor compound, [Ru(η(6)-p-phenylethacrynate)Cl(2)(pta)].
    Chakree K; Ovatlarnporn C; Dyson PJ; Ratanaphan A
    Int J Mol Sci; 2012 Oct; 13(10):13183-202. PubMed ID: 23202946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro ruthenation of human breast cancer suppressor gene 1 (BRCA1) by the antimetastasis compound RAPTA-C and its analogue CarboRAPTA-C.
    Ratanaphan A; Temboot P; Dyson PJ
    Chem Biodivers; 2010 May; 7(5):1290-302. PubMed ID: 20491084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular responses of BRCA1-defective HCC1937 breast cancer cells induced by the antimetastasis ruthenium(II) arene compound RAPTA-T.
    Nhukeaw T; Hongthong K; Dyson PJ; Ratanaphan A
    Apoptosis; 2019 Aug; 24(7-8):612-622. PubMed ID: 31016421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Cytotoxicity, Cellular Uptake, Apoptosis and Inhibition of BRCA1 Expression of BRCA1-Defective and Sporadic Breast Cancer Cells Induced by an Anticancer Ruthenium(II)-Arene Compound, RAPTA-EA1.
    Ratanaphan A; Nhukeaw T; Hongthong K; Dyson PJ
    Anticancer Agents Med Chem; 2017; 17(2):212-220. PubMed ID: 27039925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolization of [Ru(eta(6)-C (6)H (5)CF (3))(pta)Cl (2)]: a cytotoxic RAPTA-type complex with a strongly electron withdrawing arene ligand.
    Egger AE; Hartinger CG; Renfrew AK; Dyson PJ
    J Biol Inorg Chem; 2010 Aug; 15(6):919-27. PubMed ID: 20364440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fine-tuning the cytotoxicity of ruthenium(II) arene compounds to enhance selectivity against breast cancers.
    Pereira SAP; Romano-deGea J; Barbosa AI; Costa Lima SA; Dyson PJ; Saraiva MLMFS
    Dalton Trans; 2023 Aug; 52(33):11679-11690. PubMed ID: 37552495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of ruthenium(II)-arene complex [Ru(η
    Berndsen RH; Weiss A; Abdul UK; Wong TJ; Meraldi P; Griffioen AW; Dyson PJ; Nowak-Sliwinska P
    Sci Rep; 2017 Feb; 7():43005. PubMed ID: 28223694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ruthenium(II)-arene compound RAPTA-C induces apoptosis in EAC cells through mitochondrial and p53-JNK pathways.
    Chatterjee S; Kundu S; Bhattacharyya A; Hartinger CG; Dyson PJ
    J Biol Inorg Chem; 2008 Sep; 13(7):1149-55. PubMed ID: 18597125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro platination of human breast cancer suppressor gene1 (BRCA1) by the anticancer drug carboplatin.
    Ratanaphan A; Canyuk B; Wasiksiri S; Mahasawat P
    Biochim Biophys Acta; 2005 Sep; 1725(2):145-51. PubMed ID: 16099593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of organometallic ruthenium-arene anticancer drugs that resist hydrolysis.
    Ang WH; Daldini E; Scolaro C; Scopelliti R; Juillerat-Jeannerat L; Dyson PJ
    Inorg Chem; 2006 Oct; 45(22):9006-13. PubMed ID: 17054361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ruthenium(II) arene PTA (RAPTA) complexes: impact of enantiomerically pure chiral ligands.
    Kilpin KJ; Cammack SM; Clavel CM; Dyson PJ
    Dalton Trans; 2013 Feb; 42(6):2008-14. PubMed ID: 23187957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organometallic Ru(II), Rh(III) and Re(I) complexes of sterane-based bidentate ligands: synthesis, solution speciation, interaction with biomolecules and anticancer activity.
    Pivarcsik T; Kiss MA; Rapuš U; Kljun J; Spengler G; Frank É; Turel I; Enyedy ÉA
    Dalton Trans; 2024 Mar; 53(11):4984-5000. PubMed ID: 38406993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of mismatch repair protein MutS to mispaired DNA adducts of intercalating ruthenium(II) arene complexes.
    Castellano-Castillo M; Kostrhunova H; Marini V; Kasparkova J; Sadler PJ; Malinge JM; Brabec V
    J Biol Inorg Chem; 2008 Aug; 13(6):993-9. PubMed ID: 18491151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Energetics, conformation, and recognition of DNA duplexes modified by monodentate Ru(II) complexes containing terphenyl arenes.
    Novakova O; Malina J; Suchankova T; Kasparkova J; Bugarcic T; Sadler PJ; Brabec V
    Chemistry; 2010 May; 16(19):5744-54. PubMed ID: 20376825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and biophysical characterization of ruthenation of BRCA1 RING protein by RAPTA complexes and its E3 ubiquitin ligase activity.
    Temboot P; Lee RFS; Menin L; Patiny L; Dyson PJ; Ratanaphan A
    Biochem Biophys Res Commun; 2017 Jun; 488(2):355-361. PubMed ID: 28501617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bifunctional organometallic ruthenium drug with multiple modes of inducing apoptosis.
    Chatterjee S; Biondi I; Dyson PJ; Bhattacharyya A
    J Biol Inorg Chem; 2011 Jun; 16(5):715-24. PubMed ID: 21437708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of new hydridotris(pyrazolyl)borate ruthenium(II) complexes containing the phosphanes PTA and 1-CH3-PTA.
    García-Fernández A; Díez J; Manteca A; Sánchez J; García-Navas R; Sierra BG; Mollinedo F; Gamasa MP; Lastra E
    Dalton Trans; 2010 Nov; 39(42):10186-96. PubMed ID: 20882255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA interactions of monofunctional organometallic ruthenium(II) antitumor complexes in cell-free media.
    Novakova O; Chen H; Vrana O; Rodger A; Sadler PJ; Brabec V
    Biochemistry; 2003 Oct; 42(39):11544-54. PubMed ID: 14516206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-metastatic effects of RAPTA-C conjugated polymeric micelles on two-dimensional (2D) breast tumor cells and three-dimensional (3D) multicellular tumor spheroids.
    Lu H; Blunden BM; Scarano W; Lu M; Stenzel MH
    Acta Biomater; 2016 Mar; 32():68-76. PubMed ID: 26689468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organometallic ruthenium(II) diamine anticancer complexes: arene-nucleobase stacking and stereospecific hydrogen-bonding in guanine adducts.
    Chen H; Parkinson JA; Parsons S; Coxall RA; Gould RO; Sadler PJ
    J Am Chem Soc; 2002 Mar; 124(12):3064-82. PubMed ID: 11902898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.